Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEDIPASVIR\SOFOSBUVIR Cause Nasopharyngitis? 202 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 202 reports of Nasopharyngitis have been filed in association with LEDIPASVIR\SOFOSBUVIR. This represents 0.9% of all adverse event reports for LEDIPASVIR\SOFOSBUVIR.

202
Reports of Nasopharyngitis with LEDIPASVIR\SOFOSBUVIR
0.9%
of all LEDIPASVIR\SOFOSBUVIR reports
4
Deaths
24
Hospitalizations

How Dangerous Is Nasopharyngitis From LEDIPASVIR\SOFOSBUVIR?

Of the 202 reports, 4 (2.0%) resulted in death, 24 (11.9%) required hospitalization, and 1 (0.5%) were considered life-threatening.

Is Nasopharyngitis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEDIPASVIR\SOFOSBUVIR. However, 202 reports have been filed with the FAERS database.

What Other Side Effects Does LEDIPASVIR\SOFOSBUVIR Cause?

Fatigue (4,609) Headache (4,203) Nausea (1,471) Drug ineffective (1,397) Hepatitis c (1,076) Diarrhoea (1,065) Insomnia (1,021) Hepatocellular carcinoma (640) Vomiting (623) Dizziness (604)

What Other Drugs Cause Nasopharyngitis?

ADALIMUMAB (13,753) ETANERCEPT (12,421) METHOTREXATE (8,046) TOFACITINIB (7,781) SECUKINUMAB (7,022) TOCILIZUMAB (6,664) RITUXIMAB (6,321) ABATACEPT (6,143) INFLIXIMAB (5,353) CERTOLIZUMAB PEGOL (5,295)

Which LEDIPASVIR\SOFOSBUVIR Alternatives Have Lower Nasopharyngitis Risk?

LEDIPASVIR\SOFOSBUVIR vs LEFLUNOMIDE LEDIPASVIR\SOFOSBUVIR vs LEMBOREXANT LEDIPASVIR\SOFOSBUVIR vs LENACAPAVIR LEDIPASVIR\SOFOSBUVIR vs LENALIDOMIDE LEDIPASVIR\SOFOSBUVIR vs LENIOLISIB

Related Pages

LEDIPASVIR\SOFOSBUVIR Full Profile All Nasopharyngitis Reports All Drugs Causing Nasopharyngitis LEDIPASVIR\SOFOSBUVIR Demographics